Acadian Asset Management’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
Other funds holding LUNG
SCM
ECM
AC
SCM
B
Acadian Asset Management's LUNG Position: Q2 2026 in Review
Acadian Asset Management increased its Pulmonx (LUNG) stake by 34% in Q2 2026, buying an estimated $78.2K and bringing the position to 223,141 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #1573.
Acadian Asset Management first reported a position in LUNG in Q2 2023 and has held it in 6 quarters since. The position peaked at $391K in Q4 2025. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.
- Acadian Asset Management held 223,141 shares of Pulmonx worth $287K as of Q2 2026.
- Acadian Asset Management bought 56,800 Pulmonx shares in Q2 2026, an estimated $78.2K.
- Pulmonx made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1573 holding.
- Acadian Asset Management first reported a position in Pulmonx in Q2 2023 and has held it in 6 quarters since.
- Acadian Asset Management's Pulmonx position peaked at $391K in Q4 2025.
- 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.